Adalimumab (Humira)
From the هضم DIGEST medical team · GI, liver and endoscopy · Riyadh

Overview
Adalimumab is a fully human monoclonal antibody that targets TNF-α. Unlike infliximab, it is given as a self-administered subcutaneous injection, making it more convenient for many patients. It is approved for Crohn's disease and ulcerative colitis, as well as several other inflammatory conditions.
Key Uses
Moderate-to-severe Crohn's disease
Moderate-to-severe ulcerative colitis
Crohn's fistulising disease
Patients who prefer self-injection over clinic infusion
Also approved for rheumatoid arthritis, psoriasis, and psoriatic arthritis
How It Works
Fully human antibody that binds and neutralises TNF-α
Induction: 160 mg at week 0, 80 mg at week 2; maintenance: 40 mg every 2 weeks
Self-administered subcutaneous injection (abdomen or thigh)
Pre-filled pens and syringes available; store in refrigerator
Biosimilars (Amgevita, Hyrimoz, Hadlima) are widely available
Safety & Self-Care
Screen for TB and hepatitis B before starting
Rotate injection sites to avoid skin reactions at the same spot
Take the pen out of the refrigerator 15–30 minutes before injecting to reduce discomfort
Report any signs of infection, unusual fatigue, or new skin changes
Avoid live vaccines; keep inactivated vaccines up to date
Set a recurring reminder for every 2-week injection day
Contact Your IMCC Team
Contact your IMCC team if you develop infection signs, symptoms worsen, you are planning a pregnancy, or before any procedure or vaccination.
What adalimumab is and how it is used
Adalimumab is an anti-TNF biologic, like infliximab, that blocks a protein driving inflammation. It is used for moderate to severe Crohn's disease and ulcerative colitis, and also for rheumatoid arthritis, psoriasis, uveitis and other inflammatory conditions. Unlike infliximab, it is given as an injection under the skin, which most people learn to do themselves at home with a pre-filled pen or syringe, usually every one to two weeks after a starting phase. Biosimilar versions exist. It is prescribed and monitored by a specialist.
Side effects, safety and monitoring
Common effects are redness, pain or itching at the injection site, headache and upper respiratory infections. Like other anti-TNF drugs it raises the risk of infections and can reactivate tuberculosis or hepatitis B, so you are screened before starting. Rarely it can cause serious infections, a lupus-like reaction, nerve problems or blood count changes. Tell your doctor about fever or infection before an injection, as the dose may need to be delayed. Store the pens in the refrigerator as directed, and avoid live vaccines. Regular blood tests and clinical review check that it is working and safe.
Frequently Asked Questions
What is adalimumab used for?
How do you inject adalimumab?
What are the side effects of adalimumab?
Can I take adalimumab if I have an infection?
How should adalimumab be stored?
Share this with someone who needs it:
Have questions or need a consultation?
Our GI specialists are ready to help you
Same-week appointments · WhatsApp replies during working hours